Table 1.

Clinicopathologic parameters of gastric cancer subgroups.

Parameters	total	Subtype					P-value
		EBV	MSI	EMT	p53-ab	p53-wt
Sex							0.0002
female	112	2	13	25	36	36
male	309	30	21	49	147	62
Age*	57.5±0.6	56.8±2.0	67.8±2.1	56.2±1.4	59.5±0.9	52.8±1.3	<0.0001
WHO							<0.0001
well diff	32	2	4	0	21	5
mod diff	147	4	16	8	91	28
poorly diff	147	27	13	27	53	29
signet ring cell	73	0	0	28	11	34
others	22	1	1	11	7	2
Lauren							<0.0001
intestinal	176	9	18	52	107	31
diffuse	170	14	9	11	42	53
mixed	72	9	7	10	32	14
undetermined	3	0	0	0	2	0
EBV							<0.0001
negative	381	0	34	72	179	96
positive	32	32	0	0	0	0
MSI							<0.0001
stable	387	32	0	74	183	98
unstable	34	0	34	0	0	0
E-cadherin							<0.0001
aberrant	82	3	5	74	0	0
normal	331	24	26	0	183	98
p53 status
mutant	229	4	14	28	180	0	<0.0001
wildtype	179	23	17	41	0	98
T stage**							0.0037
T1	112	12	5	11	47	37
T2	64	3	11	9	25	16
T3	151	10	15	34	65	27
T4	94	7	3	20	46	18
N stage**							0.2168
N0	176	18	15	25	69	49
N1	58	4	6	7	27	14
N2	58	5	5	12	24	12
N3	129	5	8	30	63	23
TNM stage**							0.0110
I	141	13	9	16	57	46
II	94	9	12	17	38	18
III	133	5	12	31	60	25
IV	53	5	1	10	28	9

p53-wt: p53 wildtype; p53-ab: p53 aberrant

^*Age is presented as mean ± SEM (standard error of mean)

^**Based on AJCC seventh edition.